Onconetix, Inc. Debt Securities Available For Sale Excluding Accrued Interest
Onconetix, Inc. (ONCO) had Debt Securities Available For Sale Excluding Accrued Interest of $500.00 thousand as of 2024-09-24, per its 10-Q filed 2024-12-10.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2024-12-10
- 2024-09-24: Debt Securities Available For Sale Excluding Accrued Interest $500.00K.
- 2024-06-30: Debt Securities Available For Sale Excluding Accrued Interest $100.00K.
- 2024-03-31: Debt Securities Available For Sale Excluding Accrued Interest $50.00K.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2024-09-24 | $500.00K 10-Q · filed 2024-12-10 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-29 |
| 2024-03-31 | $50.00K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |